TL;DR
This study reveals that dendrobine, a natural compound, protects human umbilical vein endothelial cells (HUVECs) from endoplasmic reticulum stress (ERS)-induced apoptosis. It achieves this by upregulating microRNA miR-381-3p, which in turn suppresses the expression of caspase-4, a key mediator of ERS-induced cell death. This finding offers a potential therapeutic avenue for atherosclerosis (AS), a disease linked to endothelial cell dysfunction.
What Problem Does This Paper Address?
Atherosclerosis (AS) is a major contributor to cardiovascular diseases and is characterized by the dysfunction and apoptosis of vascular endothelial cells. Endoplasmic reticulum stress (ERS) has emerged as a significant factor contributing to this endothelial cell injury and subsequent AS development. While dendrobine has shown promise in reducing lipid levels and apoptosis, its precise molecular mechanisms in the context of ERS and AS remained unclear. This paper aims to elucidate how dendrobine exerts its protective effects on endothelial cells under ERS conditions and to identify the specific molecular pathways involved, particularly focusing on the role of microRNAs.
Methods
The researchers established an ERS model in human umbilical vein endothelial cells (HUVECs) using tunicamycin (TM). They then treated these cells with varying concentrations of dendrobine and a known ERS inhibitor, tauroursodeoxycholic acid (TUDCA), as a positive control.
Key techniques employed include:
- Cell Viability and Proliferation Assays: Cell Counting Kit-8 (CCK-8) and Bromodeoxyuridine (BrdU) staining were used to assess cell proliferation.
- Apoptosis Detection: TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assay was utilized to quantify apoptotic cells.
- Protein Expression Analysis: Western blot was performed to measure the levels of key ERS-related proteins, including GRP78, IRE1, caspase-4, CHOP, and caspase-3.
- Gene Expression Analysis: Reverse transcription-quantitative PCR (RT-qPCR) was used to determine the expression levels of miR-381-3p and caspase-4 mRNA.
- miRNA Target Validation: A dual-luciferase reporter assay was employed to confirm the direct binding of miR-381-3p to the 3' untranslated region (UTR) of caspase-4 mRNA.
- miRNA Transfection: HUVECs were transfected with miR-381-3p mimics or inhibitors to investigate the functional role of this microRNA.
Datasets
Not discussed in the paper. The study primarily relies on experimental data generated from cell cultures and molecular assays.
Key Insights and Ideas
- Dendrobine as an ERS Protector: Dendrobine effectively counteracts the detrimental effects of ERS on endothelial cells, promoting proliferation and inhibiting apoptosis. This protective effect is comparable to that of a known ERS inhibitor (TUDCA).
- miR-381-3p as a Key Mediator: The study strongly implicates miR-381-3p as a crucial player in dendrobine's protective mechanism. Dendrobine treatment leads to an upregulation of miR-381-3p, which is downregulated under ERS conditions.
- Caspase-4 as the Downstream Target: miR-381-3p directly targets and downregulates caspase-4, a critical effector caspase in ERS-induced apoptosis. This is a significant finding, as it pinpoints a specific molecular interaction responsible for the observed cellular effects.
- Dual Role of miR-381-3p: While miR-381-3p's role in regulating caspase-4 protein levels was evident, its effect on caspase-4 mRNA was less pronounced under basal conditions, suggesting post-transcriptional regulation might be a key mechanism.
- Dendrobine's Multifaceted Action: While the miR-381-3p/caspase-4 axis is a major pathway, the authors suggest that dendrobine might also influence other ERS-related pathways to achieve its overall protective effect.
Key Results
- Tunicamycin (TM) treatment induced ERS in HUVECs, leading to decreased cell proliferation and increased apoptosis.
- Dendrobine treatment (at medium concentration) significantly increased HUVEC proliferation and reduced apoptosis induced by TM.
- Dendrobine treatment also led to a decrease in the protein levels of ERS markers (GRP78, IRE1, CHOP) and apoptotic caspases (caspase-4, caspase-3).
- ERS conditions resulted in a downregulation of miR-381-3p, which was restored by dendrobine treatment.
- Dual-luciferase reporter assays confirmed that miR-381-3p directly binds to the 3' UTR of caspase-4 mRNA.
- Overexpression of miR-381-3p in HUVECs reduced caspase-4 protein levels, while inhibiting miR-381-3p reversed the protective effects of dendrobine on ERS-induced apoptosis.
- Blocking miR-381-3p significantly attenuated the beneficial effects of dendrobine on cell proliferation and apoptosis in TM-treated HUVECs.
Limitations and Future Work
- Off-target effects of miRNA manipulation: While the study used mimics and inhibitors, it's acknowledged that these can sometimes have off-target effects.
- Involvement of other pathways: The authors suggest that dendrobine's protective effects might involve other ERS-related pathways beyond the miR-381-3p/caspase-4 axis, which warrants further investigation.
- In vivo studies: The current study is limited to in vitro experiments. Future work should focus on validating these findings in animal models of atherosclerosis to assess the therapeutic potential of dendrobine in a more complex biological system.
- Clinical translation: Exploring the clinical efficacy and safety of dendrobine for AS treatment would be a crucial next step.
Summary updated